A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2002
12/10/2002	US6492389 Small molecule inhibitors of BCL-2 proteins
12/10/2002	US6492388 Such as n-(5-chloro-1,2,3,4-tetrahydroisoquinolin-7-yl)-4-ethoxybenzamide
12/10/2002	US6492387 Isoindolyl and isoquinolinyl aroyl pyrrole compounds
12/10/2002	US6492384 Imidazo (4,5-C) pyridine-4-one derivatives with factor XA inhibiting effect
12/10/2002	US6492383 Thienopyrimidine and thienopyridine derivatives useful as anticancer agents
12/10/2002	US6492382 Dried or frozen pharmaceutical preparation containing a class III antiarrhythmic compound
12/10/2002	US6492381 Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
12/10/2002	US6492380 Method of inhibiting neurotrophin-receptor binding
12/10/2002	US6492379 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor
12/10/2002	US6492378 Substituted isoquinoline derivatives and their use as anticonvulsivants
12/10/2002	US6492376 Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants
12/10/2002	US6492375 Administering a piperidine compound
12/10/2002	US6492374 Benzofuran derivatives, their preparation and use
12/10/2002	US6492373 6-fluoro-1,4-dihydro-7-[4-(2-hydroxyiminoethyl)-1-piperazinyl]-4-oxoquinoline-3-carboxylic acid derivatives, their preparation and pharmaceutical compositions
12/10/2002	US6492372 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
12/10/2002	US6492371 Use of cyclic GMP-specific phosphodiesterase inhibitors for treatment of Parkinson's Disease
12/10/2002	US6492368 Benzamidine derivatives as factor XA inhibitors
12/10/2002	US6492367 Sulfamato hydroxamic acid metalloprotease inhibitor
12/10/2002	US6492366 Cyano-indole serotonin-reuptake inhibitor compound
12/10/2002	US6492365 Microsomal triglyceride transfer protein
12/10/2002	US6492364 Triazolo and derivatives as chemokine inhibitors
12/10/2002	US6492362 Compounds and compositions as cathepsin S inhibitors
12/10/2002	US6492361 Antibiotic compositions and methods for using same
12/10/2002	US6492360 Phthalazine derivatives phosphodiesterase 4 inhibitors
12/10/2002	US6492358 For treatment of sexual disorders, male erectile dysfunction
12/10/2002	US6492356 Acylguanidine derivatives as inhibitors of bone resorption and as vitronectin receptor antagonists
12/10/2002	US6492355 Adamantane derivatives
12/10/2002	US6492354 Soluble forms of amoxicillin and treatment of animals
12/10/2002	US6492353 1,3-dihydroxy-20,20-cycloalkyl-vitamin D3analogs
12/10/2002	US6492352 Phosphonoformic acid
12/10/2002	US6492351 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith
12/10/2002	US6492349 Aminosugar and glycosaminoglycan composition for the treatment and repair of connective tissue
12/10/2002	US6492348 Adenosine derivatives
12/10/2002	US6492347 Treatment and/or prophylaxis of infection caused by protozoan parasite by administering compound to inhibit purine nucleoside hydrolase, purine nucleoside phosphorylase, and/or purine phosphoribosyl transferase
12/10/2002	US6492342 Hygromycin A prodrugs
12/10/2002	US6492341 Preparation of fagopyritols and uses therefor
12/10/2002	US6492340 Pyrrolidone solvent, bridging solvent, parasiticide
12/10/2002	US6492339 Compositions comprising D-chiro inositol and sulfonylureas and methods of treatment thereof
12/10/2002	US6492338 Therapeutic agents
12/10/2002	US6492337 Administering a ceramide
12/10/2002	US6492334 Tri-compound analgesic for treating inflammation and pain
12/10/2002	US6492333 Treatment of myeloma bone disease with proteasomal and NF-κB activity inhibitors
12/10/2002	US6492332 Irrigation solution and methods for inhibition of tumor cell adhesion, pain and inflammation
12/10/2002	US6492326 Containing a pentapeptide
12/10/2002	US6492325 Use of α1β1 integrin receptor inhibitors and TGF-β1 inhibitors in the treatment of kidney disease
12/10/2002	US6492129 Fragments comprising the n-terminal region of connective tissue growth factor (ctgf); screening for inhibitors or stimulators of ctgf
12/10/2002	US6492126 Compositions and methods for the treatment and diagnosis of cardiovascular disease
12/10/2002	US6491954 Anti-snoring composition
12/10/2002	US6491952 Beta-sitosterol and/or beta-sitostanol in a monomolecular, low associated or ?cluster? form, melt and/or solution; foods
12/10/2002	US6491951 Soluble compositions of toremifene
12/10/2002	US6491948 Increased bioavailability; preventing oxidative destabilization of dnas, rnas and proteins involved in neuronal memory processes;neuroprotective agents possessing preventive properties against memory dysfunctions
12/10/2002	US6491946 Potassium iodide, microcrystalline cellulose, hydroxypropyl methylcellulose and/or gelatin as binder; formation of iodine is surprisingly suppressed without antioxidants being present
12/10/2002	US6491945 Alkali carboxymethylcellulose, hydroxypropylalkylcellulose and a lubricant
12/10/2002	US6491944 Method for making spirillicide
12/10/2002	US6491943 Method for treating an allergic or inflammatory disease
12/10/2002	US6491940 Apparatus for administering composition for inhibiting cerebral neurovascular disorders and muscular headaches
12/10/2002	US6491938 Prevent restenosis after vascular system trauma
12/10/2002	US6491922 Methods and compounds for treating autoimmune and vascular disease
12/10/2002	US6491904 Topical composition containing human epidermal growth factor
12/10/2002	US6491903 Particles comprising amphiphilic copolymers
12/10/2002	US6491897 Solvent mixtures of water, ethanol and optionally isopropanol, propylene glycol and/or disodium ethylenediaminetetraacetate, containing drugs, used in inhalants; shelf life
12/10/2002	US6491893 Compounds for targeting and imaging infection and inflammation
12/10/2002	CA2260412C Parasiticidal pyrazoles
12/10/2002	CA2230445C Fibrinogen receptor antagonists and medicinal preparations containing the same as the active ingredient
12/10/2002	CA2228752C (1s,2s)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanol methanesulfonate trihydrate
12/10/2002	CA2209695C Use of a polyholoside in a composition to promote desquamation and the composition containing it
12/10/2002	CA2208792C Substituted indazole derivatives
12/10/2002	CA2201967C Acetamide derivative having defined particle size
12/10/2002	CA2196085C Mhc complexes and uses thereof
12/10/2002	CA2116773C Triazolylated tertiary amine compound or salt thereof
12/10/2002	CA2109934C Substituted indoles as anti-aids pharmaceuticals
12/10/2002	CA2093431C Ionically cross-linked polymeric microcapsules
12/10/2002	CA2092431C 3,9-diazabicyclo (3.3.1) nonan-7-yl derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them
12/10/2002	CA2086925C New salts derived from dialkylaminoalkysulphonyl-26 pristinamycin iib
12/10/2002	CA2084314C Starting compounds for the production of 10beta-h steroids and process for producing such starting compounds
12/10/2002	CA2080182C Nuclear inhibitor i-92 and its use for the production of a medicament
12/10/2002	CA2074580C Solid pharmaceutical composition for oral administration containing dapiprazole
12/10/2002	CA2054268C Nutritional composition
12/10/2002	CA1341408C Method for treating and preventing loss of bone mass
12/09/2002	WO2002004403A1 Biphenylcarboxylic acid amides, production thereof and use thereof as medicaments
12/09/2002	CA2412116A1 Biphenylcarboxylic acid amides, the preparation thereof and the use thereof as medicaments
12/08/2002	CA2817619A1 Methods of administering anti-tnf.alpha. antibodies
12/08/2002	CA2392486A1 Pharmaceutical dosage form bearing pregnancy-friendly indicia
12/08/2002	CA2385745A1 Methods of administering anti-tnf.alpha. antibodies
12/06/2002	WO2002039982A1 Oral formulations for localized colonic release and the method of preparation thereof
12/06/2002	CA2411045A1 Oral formulations for localized colonic release and the method of preparation thereof
12/05/2002	WO2002097395A2 P-cadherin as a target for anti-cancer therapy
12/05/2002	WO2002097120A1 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof
12/05/2002	WO2002097116A2 Delivery system for nucleic acids
12/05/2002	WO2002097087A1 Method of expressing foreign gene in kidney
12/05/2002	WO2002097075A2 Capping enzyme of flavivirus and utilization of this protein in a process to test drugs with antiviral properties
12/05/2002	WO2002097063A1 Production of bioavailable folic acid
12/05/2002	WO2002097059A2 Chromosome-based platforms
12/05/2002	WO2002097053A2 Small molecule antagonists of bcl2 family proteins
12/05/2002	WO2002097050A2 Novel estrogen receptor ligand binding domain variants and novel ligands and pharmaceutical compositions
12/05/2002	WO2002097045A2 Neuroblastoma cell lines expressing the alpha2delta subunit of calcium channels and methods therefore
12/05/2002	WO2002097043A2 Wnv core protein/capsid interacting protein and uses of the same
12/05/2002	WO2002097033A2 Antibodies that immunospecifically bind to trail receptors
12/05/2002	WO2002096952A2 Conjugate of a transport protein and a protein for modulation of notch signalling
12/05/2002	WO2002096945A2 Macrophage receptor agonist or antagonist

1 ... 5627 5628 5629 5630 5631 5632 5633 5634 5635 5636 5637 5638 5639 5640 5641 5642 5643 5644 5645 5646 5647 ... 7860